Africa/Brazil: Brazil suspends patents on ARVs

Brazil's lower house of government on Wednesday approved a bill that would suspend patents on all antiretroviral drugs and allow Brazilian companies to produce generic versions of the drugs if the Brazilian government cannot negotiate price reductions or licensing agreements with patent-holding pharmaceutical companies, Bloomberg.com reports.